Phase 2 Clinical Trial of GH001 in Bipolar II Disorder

Clinical trial NCT05839509 · TERMINATED

Trial details

NCT number: NCT05839509
Sponsor: GH Research Ireland Limited
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Bipolar II Disorder

Start date: 2023-04-06
Primary completion: 2024-11-13
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.